Switching to E-cigarette After PCI - Trial NCT06338761
Access comprehensive clinical trial information for NCT06338761 through Pure Global AI's free database. This phase not specified trial is sponsored by Samsung Medical Center and is currently Recruiting. The study focuses on Coronary Artery Disease. Target enrollment is 17442 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Samsung Medical Center
Timeline & Enrollment
N/A
Jan 01, 2024
Dec 31, 2025
Primary Outcome
MACE
Summary
Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic
 impact of switching to E-cigarettes in smokers with coronary artery disease (CAD) who
 underwent percutaneous coronary intervention (PCI) remains uncertain.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06338761
Non-Device Trial